View : 839 Download: 212
Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation
- Title
- Effect of Statin Therapy on Outcomes of Patients With Acute Ischemic Stroke and Atrial Fibrillation
- Authors
- Choi, Kang-Ho; Seo, Woo-Keun; Park, Man-Seok; Kim, Joon-Tae; Chung, Jong-Won; Bang, Oh Young; Kim, Gyeong-Moon; Song, Tae-Jin; Kim, Bum Joon; Heo, Sung Hyuk; Jung, Jin-Man; Oh, Kyung-Mi; Kim, Chi Kyung; Yu, Sungwook; Park, Kwang-Yeol; Kim, Jeong-Min; Park, Jong-Ho; Choi, Jay Chol; Hwang, Yang-Ha; Kim, Yong-Jae
- Ewha Authors
- 송태진
- SCOPUS Author ID
- 송태진
- Issue Date
- 2019
- Journal Title
- JOURNAL OF THE AMERICAN HEART ASSOCIATION
- ISSN
- 2047-9980
- Citation
- JOURNAL OF THE AMERICAN HEART ASSOCIATION vol. 8, no. 24
- Keywords
- atrial fibrillation; ischemic stroke; NACCE; outcome; statin
- Publisher
- WILEY
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Background There is insufficient evidence on the effect of statins, particularly high-intensity statins, in patients with acute ischemic stroke and atrial fibrillation. We investigated the impact of statins on the outcomes in these patients, including those who might be vulnerable to statin therapy and those without clinical atherosclerotic cardiovascular diseases. Methods and Results A total of 2153 patients with acute ischemic stroke and atrial fibrillation were enrolled in the present nationwide, multicenter, cohort study. The primary composite end point was the occurrence of net adverse clinical and cerebral events (NACCE; death from any cause, stroke, acute coronary syndrome, or major bleeding) over a 3-year period based on statin intensity. NACCE rates were lower in patients receiving low- to moderate-intensity (adjusted hazard ratio 0.64; 95% CI: 0.52-0.78) and high-intensity statins (hazard ratio 0.51; 95% CI 0.40-0.66) than in those not receiving statin therapy. High-intensity statins were associated with a lower risk for NACCE than low- to moderate-intensity statins (hazard ratio 0.76; 95% CI 0.59-0.96). Subgroup analyses showed that the differences in hazard ratio for 3-year NACCE favored statin use across all subgroups, including older patients, those with low cholesterol levels, patients receiving anticoagulants, and patients without clinical atherosclerotic cardiovascular diseases. Magnified benefits of high-intensity statins compared with low- to moderate-intensity statins were observed in patients who underwent revascularization therapy and those under 75 years of age. Conclusions Statins, particularly high-intensity statins, could reduce the risk for NACCE in patients with acute ischemic stroke and atrial fibrillation; this needs to be further explored in randomized controlled trials.
- DOI
- 10.1161/JAHA.119.013941
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
-
Effect of Statin Therapy.pdf(2 MB)
Download
- Export
- RIS (EndNote)
- XLS (Excel)
- XML